InVera MedicalTM is a medical device company developing the next-generation medical device treatment for all venous disease patients. Formerly known as Venari Medical. Our InVeraTM device is a more effective, less invasive, and faster treatment for all venous disease patients. It is uniquely positioned to disrupt current treatment practices which have seen only medium level innovation in the past decade. The team is based at Ireland's medtech cluster in Galway. Only 1.3 million of the 120 million people in the US & EU who suffer from venous disease currently receive endovenous treatment each year. 3 million venous ulcer patients are completely unserved, using ineffective compression bandaging. InVera MedicalTM offers an unrivalled lower risk and unparalleled effective non-thermal treatment which will allow more patients who suffer from Venous Disease to access effective treatment. The indication for the use of superficial venous ablation is also set to widen to treat venous ulcers which currently incur annual costs of $33Bn to insurers in the US & EU. The InVeraTM technology can be used as a safe and effective treatment for the whole spectrum of Venous Disease from varicose veins to active venous ulcers." title="" class="btn" data-container="body" data-html="true" data-id="253850" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="InVera Medical"> 2,559
Activities
Technologies
Entity types
Location
Old Dublin Rd, Galway, Ireland
Galway
Ireland
Employees
Scale: 2-10
Estimated: 13
Engaged catalyst
0Added in Motherbase
4 months, 1 week agoDeveloping the world's first pain-free and effective medical device treatment for all chronic venous disease sufferers.
InVera MedicalTM is a medical device company developing the next-generation medical device treatment for all venous disease patients. Formerly known as Venari Medical.
Our InVeraTM device is a more effective, less invasive, and faster treatment for all venous disease patients. It is uniquely positioned to disrupt current treatment practices which have seen only medium level innovation in the past decade. The team is based at Ireland's medtech cluster in Galway.
Only 1.3 million of the 120 million people in the US & EU who suffer from venous disease currently receive endovenous treatment each year. 3 million venous ulcer patients are completely unserved, using ineffective compression bandaging. InVera MedicalTM offers an unrivalled lower risk and unparalleled effective non-thermal treatment which will allow more patients who suffer from Venous Disease to access effective treatment.
The indication for the use of superficial venous ablation is also set to widen to treat venous ulcers which currently incur annual costs of $33Bn to insurers in the US & EU. The InVeraTM technology can be used as a safe and effective treatment for the whole spectrum of Venous Disease from varicose veins to active venous ulcers.